1248 results
Thumbnail

D3.179 - Longitudinal breath profiling of exhaled volatile organic compounds differentiates viral-induced asthma exacerbation from clinical control

Thumbnail

D3.183 - Determination of IgE antibodies against recombinant allergens (Phl p 1 and Phl p 5) in a random sample of patients from Madrid with pollinosis before and after one year of subcutaneous immunotherapy

Thumbnail

D3.184 - Comparative immunogenicity of mixed versus individual extracts from the storage mites Acarus siro and Tyrophagus putrescentiae

Thumbnail

D3.185 - Clinical Characteristics of Patients with Hymenoptera Venom Allergy Treated with Venom Immunotherapy: A Retrospective Study

Thumbnail

D3.187 - Sustained Clinical Benefit of Allergen Immunotherapy in Allergic Rhinitis: A Real-Life Study

Thumbnail

D3.188 - Real-Life Effectiveness of Subcutaneous Allergen Immunotherapy Assessed by Medication Consumption: A Retrospective Cohort Study

Thumbnail

D3.190 - Protocol for a real-world Study to Track Response to Oralair in Naïve patients with Grass pollen allergy (STRONG) in the Netherlands

Thumbnail

D3.191 - Demonstrating the Stability of Allergoids, the Next Generation of Allergen Therapy

Thumbnail

D3.192 - Safety of AIT with Depigmented-polymerized extracts in patients with severe allergic asthma. A subanalysis of the SAGITAL study

Thumbnail

D3.195 - Building expert consensus on the positioning of allergen immunotherapy (AIT) within a treatment paradigm for allergic rhinitis/rhinoconjunctivitis led by disease remission: A Delphi consensus

Thumbnail

D3.196 - Safety of subcutaneous immunotherapy with purified native protein Cup a 1, a major allergen of Cupressus arizonica: 6-year real-world data

Thumbnail

D3.198 - Challenges of using clinical scores as primary endpoints in allergology trials

Thumbnail

D3.199 - Severe systemic allergic reaction following violation of elimination diet in a patient with sensitization despite achieved remission on allergen-specific immunotherapy

Thumbnail

D3.200 - Broad profile of olive pollen sensitisation as a key factor in immunotherapy failure

Thumbnail

D3.201 - Subcutaneous immunotherapy with a depigmented cat allergoid is safe in patients with cat allergy and beneficial for mental health in adolescents

Thumbnail

D3.202 - Characterising relevant major allergens beyond modification: from allergen to allergoid

Thumbnail

D3.203 - Characterisation of relevant allergens in grass pollen extracts

Thumbnail

D3.205 - Two-year Outcomes of Multiple Low-Dose Oral Immunotherapies for combination of Tree Nuts or Peanut for Severe Allergy Patients

Thumbnail

D3.206 - Pollen-Food Allergy Syndrome (PFAS): A New Paradigm in Allergy Practice – Results of a Survey Among Allergists

Thumbnail

D3.207 - Symptomatology and Sensitization Profiles of Patients Undergoing Subcutaneous Immunotherapy for Aeroallergens in Greece